Source: Eur Respir J, 56 (5) 2000260; 10.1183/13993003.00260-2020
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Celeste M. Porsbjerg, Asger Sverrild, Clare M. Lloyd, Andrew N. Menzies-Gow, Elisabeth H. Bel. Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics. Eur Respir J, 56 (5) 2000260; 10.1183/13993003.00260-2020

Member's Comments

No comment yet.

Related content which might interest you: Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - MP7 - Targeting airway inflammation in asthma: current and future therapies Year: 2009 Targeting airway inflammation in asthma: current and future therapies Source: Annual Congress 2009 - PG13 Asthma: pathology and treatment Year: 2009 The effects of the new technology with detensor-method in children with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 495s Year: 2003 Role of airway responsivenes in asthma monitoring: new horizons Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006 Airway inflammation in asthma: current and future targets and therapies Source: Breathe 2010; 6: 245-252 Year: 2010 Anti-IL-5 therapy and the airway microbiome in asthma. Source: Virtual Congress 2020 – Recent innovations regarding the mechanisms and treatments of asthma Year: 2020 Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment Source: Eur Respir J 2008; 31: 1145-1147 Year: 2008 Understanding the behaviours of inhaled biologicals at the airway epithelium Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments Year: 2019 Bronchial asthma: New approach to airways functional diagnostics Source: Annual Congress 2012 - Going with the flow: assessment and evaluation of airway function and its role in patient management Year: 2012 Gene expression signatures in airway and nasal epithelium of COPD: linking endotypes to clinical outcomes Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes Year: 2017 Anti-IgE treatment, airway inflammation and remodelling in severe allergic asthma: current knowledge and future perspectives Source: Eur Respir Rev 2015; 24: 594-601 Year: 2015 In vivo evaluation of the airway epithelium in a murine model of allergic asthma: effects of bronchodilators on ciliary beat frequency Source: Eur Respir J 2006; 28: Suppl. 50, 219s Year: 2006 Galectn-3 : marker of airway inflammation in bronchial asthma Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Metabolic differences in bronchial epithelium from asthma patients and impact of bronchial thermoplasty Source: Virtual Congress 2020 – Metabolic alterations and ageing in lung disease Year: 2020 Meta-analysis of airway epithelium gene expression in asthma Source: Eur Respir J, 51 (5) 1701962; 10.1183/13993003.01962-2017 Year: 2018 Neuroregulatorial therapy of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 55s Year: 2002 Is the paediatric nasal epithelium a surrogate model for the bronchial epithelium in asthma? Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009 Novel concepts in airway inflammation and remodelling in asthma Source: Eur Respir J 2015; 46: 1796-1804 Year: 2015 Mucosal cryobiopsies – a new method for studying airway pathology in asthma Source: Virtual Congress 2021 – Bronchoscopy in the COVID - 19 era: cryobiopsy Year: 2021 A comparative analysis of the non-specific bronchial hyperreactivity in patients with newly discovered bronchial asthma combined with allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 235s Year: 2006